Loading...

Stuart Alan Green

Title(s)Health Sciences Professor, Orthopaedic Surgery
Phone(714) 456-5759
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    STRUCTURAL BASIS OF BETA1-ADRENERGIC RECEPTOR FUNCTION
    NIH/NHLBI K08HL003346Aug 1, 1995 - Jul 31, 2000
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Gilhooly D, Green SA, McCann C, Black N, Moonesinghe SR. Barriers and facilitators to the successful development, implementation and evaluation of care bundles in acute care in hospital: a scoping review. Implement Sci. 2019 05 06; 14(1):47. PMID: 31060625.
      View in: PubMed
    2. Reed JE, Green S, Howe C. Translating evidence in complex systems: a comparative review of implementation and improvement frameworks. Int J Qual Health Care. 2019 Apr 01; 31(3):173-182. PMID: 30060185.
      View in: PubMed
    3. Muccino D, Green S. Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough. Pulm Pharmacol Ther. 2019 06; 56:75-78. PMID: 30880151.
      View in: PubMed
    4. Mitcheson HD, Samanta S, Muldowney K, Pinto CA, Rocha BA, Green S, Bennett N, Mudd PN, Frenkl TL. Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial. Eur Urol. 2019 02; 75(2):274-282. PMID: 30661513.
      View in: PubMed
    5. Kang HJ, Loftus S, DiCristina C, Green S, Pong A, Zwaan CM. Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in paediatric subjects: An analysis by age group. Pediatr Blood Cancer. 2018 10; 65(10):e27273. PMID: 29893452.
      View in: PubMed
    6. Weinstein C, Jordan K, Green SA, Camacho E, Khanani S, Beckford-Brathwaite E, Pong A, Noga SJ, Rapoport BL. Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trial. Support Care Cancer. 2018 Nov; 26(11):3773-3780. PMID: 29808377.
      View in: PubMed
    7. Green S, Beveridge E, Evans L, Trite J, Jayacodi S, Evered R, Parker C, Polledri L, Tabb E, Green J, Manickam A, Williams J, Deere R, Tiplady B. Implementing guidelines on physical health in the acute mental health setting: a quality improvement approach. Int J Ment Health Syst. 2018; 12:1. PMID: 29344082.
      View in: PubMed
    8. Reich K, Papp KA, Blauvelt A, Tyring SK, Sinclair R, Thaçi D, Nograles K, Mehta A, Cichanowitz N, Li Q, Liu K, La Rosa C, Green S, Kimball AB. Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials. Lancet. 2017 07 15; 390(10091):276-288. PMID: 28596043.
      View in: PubMed
    9. Green SA. The Evolution of Remote-Controlled Intramedullary Lengthening and Compression Nails. J Orthop Trauma. 2017 Jun; 31 Suppl 2:S2-S6. PMID: 28486283.
      View in: PubMed
    10. Wagner P, Burghardt RD, Green SA, Specht SC, Standard SC, Herzenberg JE. PRECICE® magnetically-driven, telescopic, intramedullary lengthening nail: pre-clinical testing and first 30 patients. SICOT J. 2017; 3:19. PMID: 29785927.
      View in: PubMed
    11. Green SA, Bell D, Mays N. Identification of factors that support successful implementation of care bundles in the acute medical setting: a qualitative study. BMC Health Serv Res. 2017 02 07; 17(1):120. PMID: 28173796.
      View in: PubMed
    12. Green SA. CORR Insights®: Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial. Clin Orthop Relat Res. 2016 12; 474(12):2712-2713. PMID: 27637614.
      View in: PubMed
    13. Lwembe S, Green SA, Tanna N, Connor J, Valler C, Barnes R. A qualitative evaluation to explore the suitability, feasibility and acceptability of using a 'celebration card' intervention in primary care to improve the uptake of childhood vaccinations. BMC Fam Pract. 2016 07 30; 17:101. PMID: 27475527.
      View in: PubMed
    14. Lwembe S, Green SA, Chigwende J, Ojwang T, Dennis R. Co-production as an approach to developing stakeholder partnerships to reduce mental health inequalities: an evaluation of a pilot service. Prim Health Care Res Dev. 2017 01; 18(1):14-23. PMID: 27132634.
      View in: PubMed
    15. Edmondson SD, Zhu C, Kar NF, Di Salvo J, Nagabukuro H, Sacre-Salem B, Dingley K, Berger R, Goble SD, Morriello G, Harper B, Moyes CR, Shen DM, Wang L, Ball R, Fitzmaurice A, Frenkl T, Gichuru LN, Ha S, Hurley AL, Jochnowitz N, Levorse D, Mistry S, Miller RR, Ormes J, Salituro GM, Sanfiz A, Stevenson AS, Villa K, Zamlynny B, Green S, Struthers M, Weber AE. Discovery of Vibegron: A Potent and Selective ß3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder. J Med Chem. 2016 Jan 28; 59(2):609-23. PMID: 26709102.
      View in: PubMed
    16. Weinstein C, Jordan K, Green SA, Camacho E, Khanani S, Beckford-Brathwaite E, Vallejos W, Liang LW, Noga SJ, Rapoport BL. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial. Ann Oncol. 2016 Jan; 27(1):172-8. PMID: 26449391.
      View in: PubMed
    17. Green S, Zwaan CM, Kang HJ. Aprepitant for paediatric chemotherapy-induced nausea and vomiting - Authors' reply. Lancet Oncol. 2015 Jun; 16(6):e260-1. PMID: 26065616.
      View in: PubMed
    18. Green SA, Honeybourne E, Chalkley SR, Poots AJ, Woodcock T, Price G, Bell D, Green J. A retrospective observational analysis to identify patient and treatment-related predictors of outcomes in a community mental health programme. BMJ Open. 2015 May 20; 5(5):e006103. PMID: 25995234.
      View in: PubMed
    19. Kang HJ, Loftus S, Taylor A, DiCristina C, Green S, Zwaan CM. Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial. Lancet Oncol. 2015 Apr; 16(4):385-94. PMID: 25770814.
      View in: PubMed
    20. Green SA. Giants of orthopaedic surgery: Richard J. Smith MD. Clin Orthop Relat Res. 2015 Apr; 473(4):1197-200. PMID: 25666146.
      View in: PubMed
    21. Lennox L, Green S, Howe C, Musgrave H, Bell D, Elkin S. Identifying the challenges and facilitators of implementing a COPD care bundle. BMJ Open Respir Res. 2014; 1(1):e000035. PMID: 25478183.
      View in: PubMed
    22. Lovett DA, Poots AJ, Clements JT, Green SA, Samarasundera E, Bell D. Using geographical information systems and cartograms as a health service quality improvement tool. Spat Spatiotemporal Epidemiol. 2014 Jul; 10:67-74. PMID: 25113592.
      View in: PubMed
    23. Pizzo E, Laverty AA, Phekoo KJ, AlJuburi G, Green SA, Bell D, Majeed A. A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11. J Public Health (Oxf). 2015 Sep; 37(3):529-39. PMID: 24796312.
      View in: PubMed
    24. Poots AJ, Green SA, Honeybourne E, Green J, Woodcock T, Barnes R, Bell D. Improving mental health outcomes: achieving equity through quality improvement. Int J Qual Health Care. 2014 Apr; 26(2):198-204. PMID: 24521701.
      View in: PubMed
    25. Evans L, Green S, Howe C, Sharma K, Marinho F, Bell D, Thomas P. Improving patient and project outcomes using interorganisational innovation, collaboration and co-design. London J Prim Care (Abingdon). 2014; 6(2):29-34. PMID: 25949710.
      View in: PubMed
    26. Aljuburi G, Laverty AA, Green SA, Phekoo KJ, Bell D, Majeed A. Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: observational study. J Public Health (Oxf). 2013 Dec; 35(4):510-7. PMID: 24169414.
      View in: PubMed
    27. Green SA. Giants in orthopaedic surgery: Sterling Bunnell MD. Clin Orthop Relat Res. 2013 Dec; 471(12):3750-4. PMID: 24081664.
      View in: PubMed
    28. Jones SE, Green SA, Clark AL, Dickson MJ, Nolan AM, Moloney C, Kon SS, Kamal F, Godden J, Howe C, Bell D, Fleming S, Haselden BM, Man WD. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax. 2014 Feb; 69(2):181-2. PMID: 23945168.
      View in: PubMed
    29. Woodrow SR, Green SA, Phekoo KJ, Grover VP, Lovendoski J, Anderson M, Bowden-Jones O, Foxton MR. An identification and brief advice programme for low-risk alcohol consumption in an acute medical setting: an implementation study. JRSM Short Rep. 2013 May; 4(5):2042533313476696. PMID: 23772314.
      View in: PubMed
    30. Aljuburi G, Phekoo KJ, Okoye NO, Anie K, Green SA, Nkohkwo A, Ojeer P, Ndive C, Banarsee R, Oni L, Majeed A. Patients' views on improving sickle cell disease management in primary care: focus group discussion. JRSM Short Rep. 2012 Dec; 3(12):84. PMID: 23476727.
      View in: PubMed
    31. Green SA, Poots AJ, Marcano-Belisario J, Samarasundera E, Green J, Honeybourne E, Barnes R. Mapping mental health service access: achieving equity through quality improvement. J Public Health (Oxf). 2013 Jun; 35(2):286-92. PMID: 22961469.
      View in: PubMed
    32. Green S, Sullivan P, Bell D, Barnes R. Aligning quality improvement to population health. Int J Qual Health Care. 2012 Oct; 24(5):441-2. PMID: 22941366.
      View in: PubMed
    33. Green SA, Aljuburi G, Majeed A, Okoye O, Amobi C, Banarsee R, Phekoo KJ. Characterizing emergency admissions of patients with sickle cell crisis in NHS brent: observational study. JRSM Short Rep. 2012 Jun; 3(6):37. PMID: 22768371.
      View in: PubMed
    34. Aljuburi G, Laverty AA, Green SA, Phekoo KJ, Banarsee R, Okoye NV, Bell D, Majeed A. Trends in hospital admissions for sickle cell disease in England, 2001/02-2009/10. J Public Health (Oxf). 2012 Dec; 34(4):570-6. PMID: 22653886.
      View in: PubMed
    35. Austen C, Patterson C, Poots A, Green S, Weldring T, Bell D. Using a local early warning scoring system as a model for the introduction of a national system. Acute Med. 2012; 11(2):66-73. PMID: 22685696.
      View in: PubMed
    36. Frenkl TL, Railkar R, Palcza J, Scott BB, Alon A, Green S, Schaefer W. Variability of urodynamic parameters in patients with overactive bladder. Neurourol Urodyn. 2011 Nov; 30(8):1565-9. PMID: 21674594.
      View in: PubMed
    37. Chappell GP, Xiao X, Pica-Mendez A, Varnell T, Green S, Tanaka WK, Laterza O. Quantitative measurement of cysteinyl leukotrienes and leukotriene B4 in human sputum using ultra high pressure liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 01; 879(3-4):277-84. PMID: 21227760.
      View in: PubMed
    38. Frenkl TL, Zhu H, Reiss T, Seltzer O, Rosenberg E, Green S. A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladder. J Urol. 2010 Aug; 184(2):616-22. PMID: 20639026.
      View in: PubMed
    39. Camargo CA, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, Malice MP, Legrand C, Dass SB, Knorr BA, Reiss TF. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol. 2010 Feb; 125(2):374-80. PMID: 20159247.
      View in: PubMed
    40. Morris CR, Becker AB, Piñieiro A, Massaad R, Green SA, Smugar SS, Gurner DM. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma. Ann Allergy Asthma Immunol. 2010 Feb; 104(2):161-71. PMID: 20306820.
      View in: PubMed
    41. Green SA. Let's teach moral reasoning to the next generation of doctors. Medscape J Med. 2009; 11(1):11. PMID: 19295932.
      View in: PubMed
    42. Lowenberg DW, Green SA. Advances in limb lengthening and reconstruction: editorial comment. Clin Orthop Relat Res. 2008 Dec; 466(12):2899-900. PMID: 18839264.
      View in: PubMed
    43. Green SA, Alon A, Ianus J, McNaughton KS, Tozzi CA, Reiss TF. Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinence. J Urol. 2006 Dec; 176(6 Pt 1):2535-40; discussion 2540. PMID: 17085151.
      View in: PubMed
    44. Green SA. Surgeons and shamans: the placebo value of ritual. Clin Orthop Relat Res. 2006 Sep; 450:249-54. PMID: 16735867.
      View in: PubMed
    45. Lu S, Parekh DD, Kuznetsova O, Green SA, Tozzi CA, Reiss TF. An oral selective M3 cholinergic receptor antagonist in COPD. Eur Respir J. 2006 Oct; 28(4):772-80. PMID: 16870658.
      View in: PubMed
    46. Mialet-Perez J, Green SA, Miller WE, Liggett SB. A primate-dominant third glycosylation site of the beta2-adrenergic receptor routes receptors to degradation during agonist regulation. J Biol Chem. 2004 Sep 10; 279(37):38603-7. PMID: 15247302.
      View in: PubMed
    47. Green SA, Malice MP, Tanaka W, Tozzi CA, Reiss TF. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax. 2004 Feb; 59(2):100-4. PMID: 14760145.
      View in: PubMed
    48. Green SA. The origins of modern clinical research. Clin Orthop Relat Res. 2002 Dec; (405):311-9. PMID: 12461388.
      View in: PubMed
    49. Camargo CA, Smithline HA, Malice MP, Green SA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med. 2003 Feb 15; 167(4):528-33. PMID: 12456380.
      View in: PubMed
    50. Caiozzo VJ, Green S. Editorial comment. Clin Orthop Relat Res. 2002 Oct; (403 Suppl):S2-5. PMID: 12394447.
      View in: PubMed
    51. Caiozzo VJ, Green S. Breakout session 2: muscle injury. Clin Orthop Relat Res. 2002 Oct; (403 Suppl):S120-5. PMID: 12394460.
      View in: PubMed
    52. Caiozzo VJ, Utkan A, Chou R, Khalafi A, Chandra H, Baker M, Rourke B, Adams G, Baldwin K, Green S. Effects of distraction on muscle length: mechanisms involved in sarcomerogenesis. Clin Orthop Relat Res. 2002 Oct; (403 Suppl):S133-45. PMID: 12394462.
      View in: PubMed
    53. Caiozzo VJ, Green S. Breakout session 1: muscle mechanics. Clin Orthop Relat Res. 2002 Oct; (403 Suppl):S77-80. PMID: 12394455.
      View in: PubMed
    54. Caiozzo VJ, Green S. Breakout session 3: issues related to muscle growth, atrophy, and tissue engineering. Clin Orthop Relat Res. 2002 Oct; (403 Suppl):S252-61. PMID: 12394475.
      View in: PubMed
    55. Green SA, Horton E, Baker M, Utkan A, Caiozzo V. Distraction of skeletal muscle: evolution of a rat model. Clin Orthop Relat Res. 2002 Oct; (403 Suppl):S126-32. PMID: 12394461.
      View in: PubMed
    56. Green SA, Rathz DA, Schuster AJ, Liggett SB. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). Eur J Pharmacol. 2001 Jun 15; 421(3):141-7. PMID: 11516429.
      View in: PubMed
    57. Daugherty BL, Straley KS, Sanders JM, Phillips JW, Disdier M, McEver RP, Green SA. AP-3 adaptor functions in targeting P-selectin to secretory granules in endothelial cells. Traffic. 2001 Jun; 2(6):406-13. PMID: 11389768.
      View in: PubMed
    58. Green SA. The evolution of medical technology: lessons from the Burgess Shale. Clin Orthop Relat Res. 2001 Apr; (385):260-6. PMID: 11302322.
      View in: PubMed
    59. Tynan MC, Fornalski S, McMahon PJ, Utkan A, Green SA, Lee TQ. The effects of ulnar axial malalignment on supination and pronation. J Bone Joint Surg Am. 2000 Dec; 82(12):1726-31. PMID: 11130645.
      View in: PubMed
    60. Moore JD, Mason DA, Green SA, Hsu J, Liggett SB. Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C. Hum Mutat. 1999 Sep 19; 14(3):271. PMID: 10477438.
      View in: PubMed
    61. Green SA. Orthopaedic surgeons. Inheritors of tradition. Clin Orthop Relat Res. 1999 Jun; (363):258-63. PMID: 10379330.
      View in: PubMed
    62. Yatani A, Tajima Y, Green SA. Coupling of beta-adrenergic receptors to cardiac L-type Ca2+ channels: preferential coupling of the beta1 versus beta2 receptor subtype and evidence for PKA-independent activation of the channel. Cell Signal. 1999 May; 11(5):337-42. PMID: 10376806.
      View in: PubMed
    63. Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem. 1999 Apr 30; 274(18):12670-4. PMID: 10212248.
      View in: PubMed
    64. Straley KS, Daugherty BL, Aeder SE, Hockenson AL, Kim K, Green SA. An atypical sorting determinant in the cytoplasmic domain of P-selectin mediates endosomal sorting. Mol Biol Cell. 1998 Jul; 9(7):1683-94. PMID: 9658164.
      View in: PubMed
    65. McGraw DW, Donnelly ET, Eason MG, Green SA, Liggett SB. Role of beta ARK in long-term agonist-promoted desensitisation of the beta 2-adrenergic receptor. Cell Signal. 1998 Mar; 10(3):197-204. PMID: 9607143.
      View in: PubMed
    66. Green SA, Spasoff AP, Coleman RA, Johnson M, Liggett SB. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem. 1996 Sep 27; 271(39):24029-35. PMID: 8798639.
      View in: PubMed
    67. Turki J, Lorenz JN, Green SA, Donnelly ET, Jacinto M, Liggett SB. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci U S A. 1996 Sep 17; 93(19):10483-8. PMID: 8816827.
      View in: PubMed
    68. Turki J, Green SA, Newman KB, Meyers MA, Liggett SB. Human lung cell beta 2-adrenergic receptors desensitize in response to in vivo administered beta-agonist. Am J Physiol. 1995 Nov; 269(5 Pt 1):L709-14. PMID: 7491992.
      View in: PubMed
    69. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol. 1995 Jul; 13(1):25-33. PMID: 7598936.
      View in: PubMed
    70. Turki J, Pak J, Green SA, Martin RJ, Liggett SB. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest. 1995 Apr; 95(4):1635-41. PMID: 7706471.
      View in: PubMed
    71. Green SA, Turki J, Hall IP, Liggett SB. Implications of genetic variability of human beta 2-adrenergic receptor structure. Pulm Pharmacol. 1995 Feb; 8(1):1-10. PMID: 8535093.
      View in: PubMed
    72. Masaki H, Green SA, Heiny JA, Yatani A. Beta 2-adrenergic receptor regulation of the cardiac L-type Ca2+ channel coexpressed in a fibroblast cell line. Receptor. 1995; 5(4):219-31. PMID: 8840400.
      View in: PubMed
    73. Green SA, Liggett SB. A proline-rich region of the third intracellular loop imparts phenotypic beta 1-versus beta 2-adrenergic receptor coupling and sequestration. J Biol Chem. 1994 Oct 21; 269(42):26215-9. PMID: 7929336.
      View in: PubMed
    74. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 1994 Aug 16; 33(32):9414-9. PMID: 7915137.
      View in: PubMed
    75. Green SA. Skeletal defects. A comparison of bone grafting and bone transport for segmental skeletal defects. Clin Orthop Relat Res. 1994 Apr; (301):111-7. PMID: 8156661.
      View in: PubMed
    76. Green SA, Setiadi H, McEver RP, Kelly RB. The cytoplasmic domain of P-selectin contains a sorting determinant that mediates rapid degradation in lysosomes. J Cell Biol. 1994 Feb; 124(4):435-48. PMID: 7508941.
      View in: PubMed
    77. Green SA, Cole G, Jacinto M, Innis M, Liggett SB. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem. 1993 Nov 05; 268(31):23116-21. PMID: 7901205.
      View in: PubMed
    78. Green SA, Harris NL, Wall DM, Ishkanian J, Marinow H. The Rancho mounting technique for the Ilizarov method. A preliminary report. Clin Orthop Relat Res. 1992 Jul; (280):104-16. PMID: 1611729.
      View in: PubMed
    79. Green SA, Jackson JM, Wall DM, Marinow H, Ishkanian J. Management of segmental defects by the Ilizarov intercalary bone transport method. Clin Orthop Relat Res. 1992 Jul; (280):136-42. PMID: 1611733.
      View in: PubMed
    80. Green SA, Holt BD, Liggett SB. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs. Mol Pharmacol. 1992 May; 41(5):889-93. PMID: 1350321.
      View in: PubMed
    81. Green SA, Kelly RB. Low density lipoprotein receptor and cation-independent mannose 6-phosphate receptor are transported from the cell surface to the Golgi apparatus at equal rates in PC12 cells. J Cell Biol. 1992 Apr; 117(1):47-55. PMID: 1313438.
      View in: PubMed
    82. Green SA. Osteomyelitis. The Ilizarov perspective. Orthop Clin North Am. 1991 Jul; 22(3):515-21. PMID: 1852427.
      View in: PubMed
    83. Granger BL, Green SA, Gabel CA, Howe CL, Mellman I, Helenius A. Characterization and cloning of lgp110, a lysosomal membrane glycoprotein from mouse and rat cells. J Biol Chem. 1990 Jul 15; 265(20):12036-43. PMID: 2142158.
      View in: PubMed
    84. Howe CL, Granger BL, Hull M, Green SA, Gabel CA, Helenius A, Mellman I. Derived protein sequence, oligosaccharides, and membrane insertion of the 120-kDa lysosomal membrane glycoprotein (lgp120): identification of a highly conserved family of lysosomal membrane glycoproteins. Proc Natl Acad Sci U S A. 1988 Oct; 85(20):7577-81. PMID: 3174652.
      View in: PubMed
    Stuart's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (434) concept(s)
    _
    Similar People
    People who share similar concepts with this person.
    See all (59) people
    _
    Same Department
    Search Department
    ↑